Skip to main navigation

AnaptysBio

Investor Relations

  • About
    • Overview
    • Strategy
    • Senior Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Contact
  • Science
    • Immune Cell Modulation
    • Anaptys Publications and Relevant Literature
  • Pipeline
    • Overview
    • ANB032
    • Rosnilimab
    • ANB033
    • ANB101
    • Imsidolimab
    • Partnerships
  • Investors / News
    • Overview
    • News
    • Presentations & Events
    • Governance
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Investor FAQs
    • Contact
  • Careers
    • Overview
    • Job Openings
    • Core Values
    • Total Reward Program Highlights
    • AnaptysBio Culture
  • Contact
Toggle

Alex Thompson

Stifel

    Tools

    • Print

      Print
    • Email

      Email
    • RSS Feeds

      RSS Feeds
    • Email Alerts

      Email Alerts
    • Investor Contact

      Investor Contact
    • Document Request

      Document Request
     

    AnaptysBio, Inc.

    10770 Wateridge Circle
    Suite 210
    San Diego, CA 92121-5801
    (858) 362-6295 (ph)
    info@anaptysbio.com

    • LinkedIn

    Quick Links

    • About
    • Science
    • Investors / News
    • Careers
    • Contact

    Pipeline

    • ANB032
    • Rosnilimab
    • ANB033
    • ANB101
    • Imsidolimab
    • Partnerships
    © 2023 AnaptysBio, Inc. All Rights Reserved.
    Privacy Policy | Terms Of Use